• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名患有新冠肺炎肺炎和严重低氧血症呼吸衰竭患者的清醒体外膜肺氧合治疗

Awake extracorporeal membrane oxygenation in a patient with COVID-19 pneumonia and severe hypoxemic respiratory failure.

作者信息

Soroksky A, Tocut M, Rosman Z, Dekel H

机构信息

Intensive Care Unit, Department of Medicine, Department of Cardiothoracic Surgery; Wolfson Medical Center; The Center for Autoimmune Diseases, Sheba Medical Center; Sackler Faculty of Medicine, Tel-Aviv University, Israel.

出版信息

Eur Rev Med Pharmacol Sci. 2022 Mar;26(5):1761-1764. doi: 10.26355/eurrev_202203_28246.

DOI:10.26355/eurrev_202203_28246
PMID:35302228
Abstract

OBJECTIVE

In the past few years, extracorporeal membrane oxygenation (ECMO) has been increasingly used in patients with severe respiratory insufficiency in whom mechanical ventilation (MV) had failed. MV in severe COVID-19 patients is often accompanied by high respiratory pressures and high oxygen concentrations. Thus, by "placing the lungs at rest" ECMO might spare severe COVID-19 patients from being subjected to aggressive MV. Awake ECMO is another therapeutic alternative for providing extracorporeal oxygenation and ventilation by avoiding the complications of MV.

CASE PRESENTATION

A 65-year-old male diagnosed with COVID-19 pneumonia was admitted to the intensive care unit (ICU) after deteriorating to hypoxemic respiratory failure with acute respiratory distress disorder (ARDS). Awake veno-venous (VV) ECMO was considered after receiving patient consent and was successfully implemented as an attempt to avoid invasive MV. This is one of the first cases described during the COVID-19 pandemic, in which awake VV-ECMO was used in a critically ill COVID-19 patient as a replacement therapy to conventional MV.

CONCLUSIONS

Under the appropriate conditions, awake ECMO might be a suitable alternative approach to avoid complications of aggressive MV in selected critically ill COVID-19 ARDS patients.

摘要

目的

在过去几年中,体外膜肺氧合(ECMO)越来越多地用于机械通气(MV)失败的严重呼吸功能不全患者。重症 COVID-19 患者的机械通气常伴有高呼吸压力和高氧浓度。因此,通过“让肺休息”,ECMO 可能使重症 COVID-19 患者避免接受激进的机械通气。清醒体外膜肺氧合是另一种治疗选择,可通过避免机械通气的并发症来提供体外氧合和通气。

病例介绍

一名 65 岁男性被诊断为 COVID-19 肺炎,在恶化为伴有急性呼吸窘迫综合征(ARDS)的低氧性呼吸衰竭后入住重症监护病房(ICU)。在获得患者同意后考虑采用清醒静脉 - 静脉(VV)ECMO,并成功实施,以尝试避免有创机械通气。这是 COVID-19 大流行期间描述的首批病例之一,其中清醒 VV-ECMO 被用于一名重症 COVID-19 患者,作为传统机械通气的替代疗法。

结论

在适当条件下,清醒体外膜肺氧合可能是一种合适的替代方法,可避免在选定的重症 COVID-19 ARDS 患者中采用激进机械通气的并发症。

相似文献

1
Awake extracorporeal membrane oxygenation in a patient with COVID-19 pneumonia and severe hypoxemic respiratory failure.一名患有新冠肺炎肺炎和严重低氧血症呼吸衰竭患者的清醒体外膜肺氧合治疗
Eur Rev Med Pharmacol Sci. 2022 Mar;26(5):1761-1764. doi: 10.26355/eurrev_202203_28246.
2
Optimizing the safety and efficacy of the awake venovenous extracorporeal membrane oxygenation in patients with COVID-19-related ARDS.优化 COVID-19 相关 ARDS 患者清醒 venovenous 体外膜肺氧合的安全性和疗效。
Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241282590. doi: 10.1177/17534666241282590.
3
Extracorporeal Carbon Dioxide Removal to De-escalate Venovenous Extracorporeal Membrane Oxygenation in Severe COVID-19 Acute Respiratory Distress Syndrome.体外二氧化碳清除以降低重症新型冠状病毒肺炎急性呼吸窘迫综合征患者的静脉-静脉体外膜肺氧合支持强度
J Cardiothorac Vasc Anesth. 2024 Mar;38(3):717-723. doi: 10.1053/j.jvca.2023.12.029. Epub 2023 Dec 21.
4
Venovenous Extracorporeal Membrane Oxygenation in Awake Non-Intubated Patients With COVID-19 ARDS at High Risk for Barotrauma.COVID-19 相关急性呼吸窘迫综合征高危气压伤风险的清醒非插管患者的静脉-静脉体外膜肺氧合。
J Cardiothorac Vasc Anesth. 2022 Aug;36(8 Pt B):2975-2982. doi: 10.1053/j.jvca.2022.03.011. Epub 2022 Mar 17.
5
Extracorporeal hemoadsorption in critically ill COVID-19 patients on VV ECMO: the CytoSorb therapy in COVID-19 (CTC) registry.在接受 VV ECMO 的危重症 COVID-19 患者中进行体外血液吸附:COVID-19 中的 CytoSorb 治疗(CTC)登记研究。
Crit Care. 2023 Jun 19;27(1):243. doi: 10.1186/s13054-023-04517-3.
6
Venovenous extracorporeal membrane oxygenation after cardiac arrest for acute respiratory distress syndrome caused by Legionella: a case report.心肺复苏术后军团菌导致急性呼吸窘迫综合征行静脉-静脉体外膜肺氧合治疗 1 例报告
J Cardiothorac Surg. 2024 Jan 28;19(1):27. doi: 10.1186/s13019-024-02492-6.
7
Successfully treatment of application awake extracorporeal membrane oxygenation in critical COVID-19 patient: a case report.成功应用清醒体外膜肺氧合治疗重症新型冠状病毒肺炎患者:一例报告
J Cardiothorac Surg. 2020 Dec 17;15(1):335. doi: 10.1186/s13019-020-01376-9.
8
Veno-Arterial-Venous Extracorporeal Membrane Oxygenation in a Critically Ill Patient with Coronavirus Disease 2019.COVID-19 危重症患者的静脉-动脉-静脉体外膜肺氧合。
Medicina (Kaunas). 2020 Sep 30;56(10):510. doi: 10.3390/medicina56100510.
9
Extracorporeal Membrane Oxygenation with Right Ventricular Assist Device for COVID-19 ARDS.体外膜肺氧合联合右心室辅助装置治疗 COVID-19 相关急性呼吸窘迫综合征。
J Surg Res. 2021 Aug;264:81-89. doi: 10.1016/j.jss.2021.03.017. Epub 2021 Mar 18.
10
A Successful Outcome of Veno-Venous Extracorporeal Membrane Oxygenation in Obese Patients with Respiratory Failure in the Course of COVID-19: A Report of Two Cases.肥胖 COVID-19 患者呼吸衰竭中行静脉-静脉体外膜肺氧合治疗成功:两例报告。
Int J Environ Res Public Health. 2022 Feb 27;19(5):2761. doi: 10.3390/ijerph19052761.

引用本文的文献

1
Lessons Learned From Awake ECMO Approach in Covid-19-Related Acute Respiratory Distress Syndrome - a Scoping Review.从清醒体外膜肺氧合治疗新冠病毒相关急性呼吸窘迫综合征中汲取的经验教训——一项范围综述
Ther Clin Risk Manag. 2025 May 13;21:655-668. doi: 10.2147/TCRM.S507120. eCollection 2025.
2
Patient Self-Inflicted Lung Injury-A Narrative Review of Pathophysiology, Early Recognition, and Management Options.患者自伤性肺损伤——病理生理学、早期识别及管理选择的叙述性综述
J Pers Med. 2023 Mar 28;13(4):593. doi: 10.3390/jpm13040593.